pyrazolanthrone has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breslin, P; Li, J; Liu, X; Volk, A; Zhang, J; Zhang, Z | 1 |
| Cui, J; Feng, J; Li, Y; Lv, M; Shen, B; Wang, J; Wang, Q; Zhang, J; Zhu, N | 1 |
2 other study(ies) available for pyrazolanthrone and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
The synergistic repressive effect of NF-κB and JNK inhibitor on the clonogenic capacity of Jurkat leukemia cells.
Topics: Anthracenes; Cell Proliferation; Cell Survival; Cells, Cultured; Drug Synergism; Gene Expression Regulation, Neoplastic; Hematopoietic Stem Cells; Humans; Jurkat Cells; MAP Kinase Signaling System; NF-kappa B; Nitriles; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sulfones | 2014 |
Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
Topics: Acetonitriles; Animals; Anthracenes; Apoptosis; Benzothiazoles; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MAP Kinase Kinase 7; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; RNA Interference; Transfection | 2009 |